These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity. Prayson RA Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas. Prayson RA; Mohan DS; Song P; Suh JH Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299 [TBL] [Abstract][Full Text] [Related]
5. Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature. Marton E; Feletti A; Orvieto E; Longatti P J Neurol Sci; 2007 Jan; 252(2):144-53. PubMed ID: 17189643 [TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases. Machen SK; Prayson RA Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840 [TBL] [Abstract][Full Text] [Related]
8. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600 [TBL] [Abstract][Full Text] [Related]
9. A case of anaplastic pleomorphic xanthoastrocytoma presenting with tumor bleeding and cerebrospinal fluid dissemination. Asano K; Miyamoto S; Kubo O; Kikkukawa T; Yagihashi A; Ohkuma H Brain Tumor Pathol; 2006 Apr; 23(1):55-63. PubMed ID: 18095120 [TBL] [Abstract][Full Text] [Related]
10. Increased mitotic activity as a negative prognostic indicator in pleomorphic xanthoastrocytoma. Case report. Macaulay RJ; Jay V; Hoffman HJ; Becker LE J Neurosurg; 1993 Nov; 79(5):761-8. PubMed ID: 8410257 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of malignant features in oligodendroglial tumors. Saito A; Nakazato Y Clin Neuropathol; 1999; 18(2):61-73. PubMed ID: 10192700 [TBL] [Abstract][Full Text] [Related]
12. Pleomorphic xanthoastrocytoma. Immunohistochemical methods for differentiation from fibrous histiocytomas with similar morphology. Grant JW; Gallagher PJ Am J Surg Pathol; 1986 May; 10(5):336-41. PubMed ID: 3010749 [TBL] [Abstract][Full Text] [Related]
13. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas. Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322 [TBL] [Abstract][Full Text] [Related]
14. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas]. Miyagami M; Nakamura S No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195 [TBL] [Abstract][Full Text] [Related]
15. Intraventricular pleomorphic xanthoastrocytoma with anaplastic features. Fu YJ; Miyahara H; Uzuka T; Natsumeda M; Okamoto K; Hirose T; Fujii Y; Takahashi H Neuropathology; 2010 Aug; 30(4):443-8. PubMed ID: 20051018 [TBL] [Abstract][Full Text] [Related]
16. Pigmented astrocytoma with suprasellar location: case report and literature review. Krossnes BK; Mella O; Wester K; Mørk SJ Acta Neuropathol; 2004 Nov; 108(5):461-6. PubMed ID: 15365722 [TBL] [Abstract][Full Text] [Related]
17. The expression of cell cycle regulatory proteins in oligodendroglial tumors. Kamiya M; Nakazato Y Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253 [TBL] [Abstract][Full Text] [Related]
18. Pleomorphic xanthoastrocytoma: report of two cases and brief review of the literature. Thomas C; Golden B Clin Neuropathol; 1993; 12(2):97-101. PubMed ID: 8477554 [TBL] [Abstract][Full Text] [Related]